A recent experimental treatment may offer a new method to prevent HIV infection: by combining two antiviral tactics into a single antibody. In laboratory studies, the new molecule forced the virus to ...
The virus often mutates by simply deleting small pieces of its genetic code. The mutations "disguise" the virus from antibodies.
The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical trial stages, the first COVID-19 mRNA vaccine was administered on 8 December ...
A clinical trial found a mycelium-based supplement reduced short-term vaccine side effects and increased antibody persistence ...
A public health expert says New Zealand is in its ninth wave of Covid-19. The latest Health New Zealand figures show 50 ...
Anyone with worsening symptoms should contact their doctor or Healthline. People who have a weakened immune system, high-risk ...
The COVID-19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical trial stages, the first COVID-19 mRNA vaccine was administered on 8 December ...
Researchers from Indian Institute of Science Education and Research (IISER) Mohali have discovered that unique antibodies from camels may help neutralise the dengue virus. Scientists say these tiny "n ...
NEW HAVEN, Conn., March 05, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced the appointment of Michael Mina, M.D., Ph.D., as Chief Medical Officer.
Machine learning reveals unique COVID vaccine immune signatures in people living with HIV, with differences in antibodies, cytokines, and T cell responses.
A Study shows mutation-resistant antibodies with 269×affinity, a proof point for CEPI’s 100 Days Mission and closing ...
GlobalData on MSN
BioNTech co-founders step down to launch new mRNA venture
The leadership changes arrive as BioNTech reported a 57% rise in net losses for 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results